Search
for
Sort by
Research 61–90 of 430
- Worldwide cohort study of 46, XY differences/disorders of sex development genetic diagnoses: geographic and ethnic differences in variants
- Advancements in Bioactive Compounds and Therapeutic Agents for Alopecia: Trends and Future Perspectives
- Costunolide promotes the proliferation of human hair follicle dermal papilla cells and induces hair growth in C57BL/6 mice
- Hair Growth Promotion and Anti-Hair Loss Effects of By-Products Arabica Coffee Pulp Extracts Using Supercritical Fluid Extraction
- Functional Food Nutrients, Redox Resilience Signaling and Neurosteroids for Brain Health
- Bioinformatic analysis of gene expression data reveals Src family protein tyrosine kinases as key players in androgenetic alopecia
- RE-ORGA, a Korean Herb Extract, Can Prevent Hair Loss Induced by Dihydrotestosterone in Human Dermal Papilla Cells
- Meta-analysis identifies novel risk loci and yields systematic insights into the biology of male-pattern baldness
- A Comprehensive Review: The Bidirectional Role of Sebum in Skin Health
- Phytochemical Constitution, Anti-Inflammation, Anti-Androgen, and Hair Growth-Promoting Potential of Shallot (Allium ascalonicum L.) Extract
- Synthesis and Actions of 5α-Reduced Metabolites of Testosterone in the Nervous System
- Androgenetic Alopecia in Men: An Update On Genetics
- Gender-Difference in Hair Length as Revealed by Crispr-Based Production of Long-Haired Mice with Dysfunctional FGF5 Mutations
- Comparison of In Vitro Hair Growth Promotion and Anti-Hair Loss Potential of Thai Rice By-Product from Oryza sativa L. cv. Buebang 3 CMU and Sanpatong
- The oestrogen receptor 2 (<i>ESR2</i>) gene in female-pattern hair loss: replication of association with rs10137185 in German patients
- 5α-Reduced glucocorticoids: a story of natural selection
- Molecular Mechanisms and Therapeutic Advances in Androgenetic Alopecia
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
- Consequences of steroid-5α-reductase deficiency and inhibition in vertebrates
- Androgenetic alopecia: pathogenesis and potential for therapy
- 11α-Hydroxyprogesterone, a potent 11β-hydroxysteroid dehydrogenase inhibitor, is metabolised by steroid-5α-reductase and cytochrome P450 17α-hydroxylase/17,20-lyase to produce C11α-derivatives of 21-deoxycortisol and 11-hydroxyandrostenedione in vitro
- Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers
- GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk
- SNP variation in male pattern hair loss in Russians with different dihydrotestosterone levels
- Microneedles mediated bioinspired lipid nanocarriers for targeted treatment of alopecia
- Pharmacogenetics of the Androgen Metabolic Pathway
- DNMT1 targets SRD5A2 to induce mitochondrial homeostasis and EMT in urothelial cells of hypospadias
- SRD5A2 and emerging therapies in androgen-driven disorders
- Metabolic Syndrome, Hepatic Steatosis and Testosterone: A Matter of Sex
- Antioxidation, Anti-Inflammation, and Regulation of SRD5A Gene Expression of Oryza sativa cv. Bue Bang 3 CMU Husk and Bran Extracts as Androgenetic Alopecia Molecular Treatment Substances